Benzonatate and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and Repaglinide (repaglinide). Common drug interactions include renal failure among females and adverse event among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Repaglinide. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

On Jul, 31, 2026

28 people who take Benzonatate and Repaglinide together, and have interactions are studied.

Benzonatate and Repaglinide drug interactions.

What are the common drug interactions of Benzonatate and Repaglinide, by gender? *:

female:

Renal failure (kidney dysfunction)
Blood glucose increased
Abnormal faeces (abnormal stool)
Acute respiratory failure
Aortic arteriosclerosis (hardening of the aortic arteries)
Aortic disorder
Arthralgia (joint pain)
Basophil count increased
Blood magnesium increased
Blood potassium increased

male:

Adverse event
Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Pneumonia
Renal failure (kidney dysfunction)
Seasonal allergy (allergic condition due to certain season)

What are the common drug interactions of Benzonatate and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Acute respiratory distress syndrome
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Cardiac failure congestive
Chronic kidney disease
Coma (state of unconsciousness lasting more than six hours)
Drug clearance decreased
Feeding disorder (when children refuse to eat certain food groups)
Nasopharyngitis (inflammation of the nasopharynx)
Pneumonia
Renal failure (kidney dysfunction)

50-59:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)

60+:

Abnormal faeces (abnormal stool)
Acute respiratory failure
Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)
Contusion (a type of hematoma of tissue in which capillaries)
Femur fracture
Flatulence (flatus expelled through the anus)
Haemoglobin decreased
Injury
Joint range of motion decreased (disease of joint movement)
Lymphocyte count increased

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 35.71%
High Blood Pressure: 10 people, 35.71%
Insomnia (sleeplessness): 7 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 7 people, 25.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 6 people, 21.43%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 21.43%
Arrhythmias (irregular heartbeat): 6 people, 21.43%
Productive Cough: 6 people, 21.43%
Type 2 Diabetes: 6 people, 21.43%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 17.86%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously